Ligosan

Doxycycline hyclate, the active ingredient in Ligosan, is a tetracycline antibiotic presented as a topical formulation for periodontal use. It targets bacterial pathogens responsible for gum inflammation and tissue destruction, providing a therapeutic option for patients with periodontal infections.

GNH USA supplies Ligosan as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics across global markets while adhering to EU quality standards. The company ensures traceability, proper documentation, and regulatory compliance for each shipment to meet the requirements of health authorities worldwide.

Ligosan is indicated for bacterial conditions affecting the periodontium and related oral tissues.

Periodontal infections: Reduces bacterial load and inflammation in acute gum infections. Chronic periodontitis: Helps control disease progression by inhibiting pathogenic microbes. Acute necrotizing ulcerative gingivitis: Provides antimicrobial activity to limit tissue necrosis.

Topical doxycycline may cause a range of local and systemic adverse reactions.

Common Side Effects: - Oral irritation: mild burning or soreness at the application site. - Taste alteration: temporary metallic or bitter taste. - Mild gastrointestinal upset: nausea or dyspepsia. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Clostridioides difficile infection: persistent diarrhea. - Hepatotoxicity: elevated liver enzymes.

When prescribing Ligosan, clinicians should consider several precautionary measures.

Pregnancy: Category D – use only if benefits outweigh risks. Breastfeeding: Caution – doxycycline may be excreted in milk. Renal impairment: Adjust therapy as needed for reduced clearance. Concurrent antibiotics: Avoid use with other tetracyclines to prevent antagonism. Sun exposure: Advise patients to limit UV exposure and use protection. Store at ambient temperature: keep in original container, protect from moisture and direct light.

Doxycycline can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum, calcium or magnesium: markedly reduce absorption. - Oral contraceptives: may decrease hormonal effectiveness. - Warfarin: increased anticoagulant effect, monitor INR closely.

Moderate Interactions (Monitor Closely): - Penicillins: bacteriostatic effect may antagonize bactericidal action. - Retinoids (e.g., isotretinoin): increased risk of intracranial hypertension. - Methotrexate: enhanced toxicity, monitor levels.